Arm (ARM)

The market is missing the fact that ARM’s true growth engine is shifting from pure IP licensing to the AGI CPU silicon business - licensing fell 30% QoQ while the newly‑tracked ACV metric hints at a $2 B pipeline that is still supply‑constrained. The headline record revenue masks a **binding constraint: wafer, memory and test capacity for the AGI CPU**, which caps upside until secured. Management’s favorite line, “confidence increased in the past 90 days,” is a red flag because it replaces a concrete capacity number with vague optimism. **My view changes if ARM cannot lock down the additional wafer/substrate slots needed for the $2 B pipeline by Q3**, as that would force the silicon revenue upside to evaporate and further erode margins.